CHEK1 and Miyoshi myopathy: In one study, the results of western blot analysis showed that simvastatin-induced S-phase cell cycle arrest was associated with activation of the Chk1–Cdc25A–cyclin A/CDk2 pathway and that silencing Chk1 expression inhibited simvastatin-mediated effects in MM cell lines [78].